Arrow Greentech is currently trading at Rs. 530.10, up by 21.85 points or 4.30% from its previous closing of Rs. 508.25 on the BSE.
The scrip opened at Rs. 525.00 and has touched a high and low of Rs. 537.90 and Rs. 510.65 respectively. So far 15788 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 597.70 on 06-May-2024 and a 52 week low of Rs. 256.90 on 16-May-2023.
Last one week high and low of the scrip stood at Rs. 537.90 and Rs. 480.20 respectively. The current market cap of the company is Rs. 792.12 crore.
The promoters holding in the company stood at 68.60%, while Institutions and Non-Institutions held 1.28% and 30.12% respectively.
Arrow Greentech has received a grant for patent titled ‘Process for Making Medicated Bands Which Allow Application of More than One Medication for Delivery to the Wound and Bands Made by them’ for the territory of the India under the provisions of the Indian Patent Act.
The present invention relates in general to medicated bands/bandages and covering material, and in particular to processes for making medicated bands which allow application of one or more medication to be delivered to the wound. The medication and or active ingredients are stored in a soluble core reservoir within the medicated band itself.
Arrow Greentech is engaged in business of bio-degradable (green) products, high-tech product and having Patents income for such products/technology. The company caters to both domestic and international markets.
| Company Name | CMP |
|---|---|
| Uflex | 446.40 |
| EPL | 225.10 |
| AGI Greenpac | 633.10 |
| Huhtamaki India | 179.70 |
| TCPL Packaging | 2730.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: